2-(4-oxo-2-thioxo-1,3-thiazolidin-3-yl)butanoic acid | 13242-81-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(4-oxo-2-thioxo-1,3-thiazolidin-3-yl)butanoic acid
• 英文别名: 2-(4-oxo-2-thioxo-thiazolidin-3-yl)-butyric acid；2-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoic Acid
• CAS: 13242-81-4
• 化学式: C₇H₉NO₃S₂
• 分子量: 219.285
• InChiKey: NNQBLGBOIVVEBX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  115
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-(4-溴苯基)-2-呋喃甲醛 、 2-(4-oxo-2-thioxo-1,3-thiazolidin-3-yl)butanoic acid 在 哌啶 作用下， 以 乙醇 为溶剂， 以92%的产率得到2-((5Z)-5-{[5-(4-bromophenyl)-2-furyl]methylene}-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)butanoic acid
  参考文献：
  名称：

  Rational design of apoptosis signal-regulating kinase 1 inhibitors: Discovering novel structural scaffold

  摘要：

  Increased activity of apoptosis signal-regulating kinase 1 (ASK1) is associated with a number of human disorders and the inhibitors of ASK1 may become important compounds for pharmaceutical application. Here we report novel ASK1 inhibitor scaffold, namely 5-(5-Phenyl-furan-2-ylmethylene)-2-thioxo-thiazolidin-4-one, that has been identified using virtual screening and biochemical tests. A series of derivatives has been synthesized and evaluated in vitro towards human protein kinase ASK1. It was revealed that the most active compounds 4-((5Z)-5-{[5-(4-bromophenyl)-2-furyl]methylene}-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)butanoic acid and 6-((5Z)-5-{[5-(4-bromophenyl)-2-furyl]methylene}-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)hexanoic acid inhibit ASK1 with IC50 of 0.2 mu M. Structure activity relationships of 33 derivatives of 5-(5-Phenyl-furan-2-ylmethylene)-2-thioxo-thiazolidin-4-one have been studied and binding mode of this chemical class has been predicted. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.09.022

文献信息

• RADIOACTIVE IODINE LABELED ORGANIC COMPOUND OR SALT THEREOF
  申请人：Saji Hideo

  公开号：US20120330024A1

  公开（公告）日：2012-12-27

  The present invention is a compound represented by the following formula (1) or a salt thereof. Furthermore, the present invention is an imaging agent used for imaging a tau protein, the imaging agent containing a compound represented by the formula (1) below or a salt thereof. In the formula (1), R 3 is a radioactive iodine.

  本发明是由以下式（1）表示的化合物或其盐。此外，本发明是用于成像tau蛋白的成像剂，该成像剂含有以下式（1）表示的化合物或其盐。在式（1）中，R3是放射性碘。
• Rhodanine derivatives, a process for their preparation, and aldose reductase inhibitors containing such derivatives
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP0045165B1

  公开（公告）日：1986-03-12
• US8476449B2
  申请人：——

  公开号：US8476449B2

  公开（公告）日：2013-07-02